Format

Send to

Choose Destination
See comment in PubMed Commons below
Magn Reson Imaging Clin N Am. 1996 Feb;4(1):73-85.

Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.

Author information

  • 1Department of Magnetic Resonance Imaging, New York University Medical Center, New York, USA.

Abstract

Mangafodipir trisodium (Mn-DPDP) is one of several recently developed targeted hepatobiliary agents. Contrast-to-noise measurements have shown favorable results for Mn-DPDP-enhanced MR as compared with nonenhanced T1- and T2-weighted images. An improved capability for lesion detection and the ability to characterize tumors of hepatocellular origin have been demonstrated. The prolonged enhancement obtained with Mn-DPDP provides an extended window of time during which effective contrast is maintained as compared with traditional extracellular contrast agents. This report details the experimental and initial clinical experience with Mn-DPDP-enhanced MR imaging of the abdomen.

PMID:
8673718
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk